Grant: Discovery Grants Program - Individual
University of Manitoba
$33,000.00
Harnessing the therapeutic potentials of the livestock microbiota: elucidating biochemical, antimicrobial, and immunomodulatory properties of the microbial natural products
FY 2024-25
Summary
Effective control of infectious diseases is a key determinant of economic viability and environmental sustainability of livestock production systems. Traditionally, antimicrobials have been widely used to treat, control and prevent infectious diseases on farms, but also to enhance the growth performance of livestock. However, the overuse of antimicrobials in farm animals has raised global concerns regarding its contribution to the antimicrobial resistance crisis, one of the biggest human health challenges of the 21st century. Therefore, identification of alternatives therapeutics that can effectively enhance disease resilience and production performance of farm animals is a key research priority for the agricultural sector in Canada and worldwide. The proposed research program seeks to address this challenge by harnessing the therapeutic potentials of the livestock microbiota.
One of the main mechanisms through which microbiota interact with their host and competing microorganisms is through the production of specialized secondary metabolites, known as microbial natural products (MNPs). Having evolved within host-associated microbial ecosystems, MNPs are attractive therapeutic targets as they can offer immunomodulatory and antimicrobial activities. However, despite mounting metagenomics evidence regarding the prevalence and diversity of MNPs produced by the host-associated microbiota, the therapeutic potentials of these natural resources remain largely untapped. This is mainly due to the unavailability of comprehensive isolate collections that represent phylogenetic and strain diversity of microbiotas in their natural ecosystems. My research program aims to generate extensive strain collections, genome catalogues, and MNP libraries specific to the microbiota of different species of farm animals. The ultimate goal is to identify novel microbiota-derived therapeutics for enhancing gut health, disease resilience and production performance of economically important species of farms animals. High-throughput functional screening in parallel with genome mining algorithms will be used for identification of bacterial strains and novel MNPs with potent anti-pathogen properties and/or immune-modulatory effects. Bacteriocins, non-ribosomal peptides, and polyketides are examples of MNPs targeted by this approach. Besides serving as a proxy for the discovery of novel therapeutics, the biobanks and genomic resources generated through this program hold great promise for translational microbiome research, including mechanistic investigations of the role of livestock microbiome in the emergence and spread of antimicrobial resistance, and the discovery of novel microbiota-derived enzymes for improving feed-efficiency and thus the sustainability of livestock production systems. This program will also provide excellent training opportunities for students in the fields of microbiome research, bioinformatics, advanced genomics, and small molecule discovery.
Program
Discovery Grants Program - Individual
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2023-04359
Name nom
Derakhshani, Hooman
Department département
Animal Science
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Harnessing the therapeutic potentials of the livestock microbiota: elucidating biochemical, antimicrobial, and immunomodulatory properties of the microbial natural products
Keywords
animal microbiome; bacterial genomics; metagenomics; high-throughput culturomics; biosynthetic gene clusters; microbiome therapeutics; probiotics and postbiotics; microbial natural products; antimicrobial resistance; host microbe interaction
Application summary
Effective control of infectious diseases is a key determinant of economic viability and environmental sustainability of livestock production systems. Traditionally, antimicrobials have been widely used to treat, control and prevent infectious diseases on farms, but also to enhance the growth performance of livestock. However, the overuse of antimicrobials in farm animals has raised global concerns regarding its contribution to the antimicrobial resistance crisis, one of the biggest human health challenges of the 21st century. Therefore, identification of alternatives therapeutics that can effectively enhance disease resilience and production performance of farm animals is a key research priority for the agricultural sector in Canada and worldwide. The proposed research program seeks to address this challenge by harnessing the therapeutic potentials of the livestock microbiota.
One of the main mechanisms through which microbiota interact with their host and competing microorganisms is through the production of specialized secondary metabolites, known as microbial natural products (MNPs). Having evolved within host-associated microbial ecosystems, MNPs are attractive therapeutic targets as they can offer immunomodulatory and antimicrobial activities. However, despite mounting metagenomics evidence regarding the prevalence and diversity of MNPs produced by the host-associated microbiota, the therapeutic potentials of these natural resources remain largely untapped. This is mainly due to the unavailability of comprehensive isolate collections that represent phylogenetic and strain diversity of microbiotas in their natural ecosystems. My research program aims to generate extensive strain collections, genome catalogues, and MNP libraries specific to the microbiota of different species of farm animals. The ultimate goal is to identify novel microbiota-derived therapeutics for enhancing gut health, disease resilience and production performance of economically important species of farms animals. High-throughput functional screening in parallel with genome mining algorithms will be used for identification of bacterial strains and novel MNPs with potent anti-pathogen properties and/or immune-modulatory effects. Bacteriocins, non-ribosomal peptides, and polyketides are examples of MNPs targeted by this approach. Besides serving as a proxy for the discovery of novel therapeutics, the biobanks and genomic resources generated through this program hold great promise for translational microbiome research, including mechanistic investigations of the role of livestock microbiome in the emergence and spread of antimicrobial resistance, and the discovery of novel microbiota-derived enzymes for improving feed-efficiency and thus the sustainability of livestock production systems. This program will also provide excellent training opportunities for students in the fields of microbiome research, bioinformatics, advanced genomics, and small molecule discovery.